Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350392 ((S)-4-amino-6-((1-(6-phenylimidazo[1,2-b]pyridazin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350430 (US10208066, Compound 49 | US10611777, Compound 49) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350438 (US10208066, Compound 60 | US10611777, Compound 60) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350430 (US10208066, Compound 49 | US10611777, Compound 49) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350447 ((S)-4-amino-6-((1-(3-chloro-6-(2-hydroxyphenyl)imi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350389 (4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350398 (US10208066, Compound 15 | US10611777, Compound 15) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350454 ((S)-4-amino-6-(0-(3-fluoro-6-phenylimidazo[1,2-b]p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350402 (US10208066, Compound 19 | US10611777, Compound 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350405 (US10208066, Compound 22 | US10611777, Compound 22) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350443 (US10208066, Compound 65 | US10611777, Compound 65) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350446 (US10208066, Compound 68 | US10611777, Compound 68) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350396 (US10208066, Compound 12 | US10611777, Compound 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436060 (US10611777, Compound 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436131 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350453 (US10208066, Compound 77 | US10611777, Compound 77) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350407 (US10208066, Compound 24 | US10611777, Compound 24) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350421 (US10208066, Compound 40 | US10611777, Compound 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350440 (US10208066, Compound 62 | US10611777, Compound 62) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436129 ((chiral)-4-amino-6-((1-(3-chloro-6-(3-(2-hydroxypr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350434 (US10208066, Compound 54 | US10611777, Compound 54) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350412 ((S)-4-amino-6-((1-(3-chloro-6-(3,5-difluorophenyl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350426 (US10208066, Compound 45 | US10611777, Compound 45) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436061 (US10611777, Compound 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350422 (US10208066, Compound 41 | US10611777, Compound 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350397 (US10208066, Compound 13 | US10611777, Compound 13) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350399 (US10208066, Compound 16 | US10611777, Compound 16) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350417 (US10208066, Compound 36 | US10611777, Compound 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350411 (US10208066, Compound 29 | US10611777, Compound 29) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436084 ((S)-4-amino-6-((1-(3-chloro-6-(o-tolyl)imidazo[1,2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350427 (US10208066, Compound 46 | US10611777, Compound 46) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436078 (US10611777, Compound 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350416 (US10208066, Compound 35 | US10611777, Compound 35) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350401 (US10208066, Compound 18 | US10611777, Compound 18) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350450 (US10208066, Compound 72 | US10611777, Compound 72) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350437 (US10208066, Compound 59 | US10611777, Compound 59) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350445 (US10208066, Compound 67 | US10611777, Compound 67) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436076 (US10611777, Compound 23) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350441 (US10208066, Compound 63 | US10611777, Compound 63) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436074 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350439 (US10208066, Compound 61 | US10611777, Compound 61) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350434 (US10208066, Compound 54 | US10611777, Compound 54) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350444 (US10208066, Compound 66 | US10611777, Compound 66) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350452 (US10208066, Compound 74 | US10611777, Compound 74) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350429 (US10208066, Compound 48 | US10611777, Compound 48) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350393 ((S)-4-amino-6-((1-(3-chloro-6-(pyridin-2-yl)imidaz...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350432 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436132 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350414 (US10208066, Compound 32 | US10611777, Compound 32) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350428 (US10208066, Compound 47 | US10611777, Compound 47) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350448 (US10208066, Compound 70 | US10611777, Compound 70) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350447 ((S)-4-amino-6-((1-(3-chloro-6-(2-hydroxyphenyl)imi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436080 ((S)-7-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350400 (US10208066, Compound 17 | US10611777, Compound 17) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350388 (4-amino-6-((1-(6-phenylimidazo[1,2-b]pyridazin-7-y...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350438 (US10208066, Compound 60 | US10611777, Compound 60) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436060 (US10611777, Compound 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350438 (US10208066, Compound 60 | US10611777, Compound 60) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350390 ((R)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350442 (US10208066, Compound 64 | US10611777, Compound 64) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350427 (US10208066, Compound 46 | US10611777, Compound 46) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350435 (US10208066, Compound 57 | US10611777, Compound 57) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350419 (US10208066, Compound 38 | US10611777, Compound 38) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 66 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350403 ((s)-9-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350420 (US10208066, Compound 39 | US10611777, Compound 39) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350432 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350396 (US10208066, Compound 12 | US10611777, Compound 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350451 (US10208066, Compound 73 | US10611777, Compound 73) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 87 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350450 (US10208066, Compound 72 | US10611777, Compound 72) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436061 (US10611777, Compound 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG UniChem | US Patent | n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436131 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350441 (US10208066, Compound 63 | US10611777, Compound 63) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350449 (US10208066, Compound 71 | US10611777, Compound 71) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 129 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436095 ((R)-4-amino-6-((1-(3-chloro-6-(3-fluorophenyl)imid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 132 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350447 ((S)-4-amino-6-((1-(3-chloro-6-(2-hydroxyphenyl)imi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 133 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350436 (US10208066, Compound 58 | US10611777, Compound 58) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 138 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436084 ((S)-4-amino-6-((1-(3-chloro-6-(o-tolyl)imidazo[1,2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 146 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350430 (US10208066, Compound 49 | US10611777, Compound 49) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 146 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM436060 (US10611777, Compound 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350389 (4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 168 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350411 (US10208066, Compound 29 | US10611777, Compound 29) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 174 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350426 (US10208066, Compound 45 | US10611777, Compound 45) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 195 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436132 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 203 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350434 (US10208066, Compound 54 | US10611777, Compound 54) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 226 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350453 (US10208066, Compound 77 | US10611777, Compound 77) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 238 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350414 (US10208066, Compound 32 | US10611777, Compound 32) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350417 (US10208066, Compound 36 | US10611777, Compound 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350440 (US10208066, Compound 62 | US10611777, Compound 62) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 247 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 272 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350421 (US10208066, Compound 40 | US10611777, Compound 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 277 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350425 (US10208066, Compound 44 | US10611777, Compound 44) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 283 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436086 ((S)-4-((1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 288 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM350418 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 288 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350392 ((S)-4-amino-6-((1-(6-phenylimidazo[1,2-b]pyridazin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 303 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350405 (US10208066, Compound 22 | US10611777, Compound 22) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 322 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350389 (4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 323 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350399 (US10208066, Compound 16 | US10611777, Compound 16) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 326 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350442 (US10208066, Compound 64 | US10611777, Compound 64) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >333 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350421 (US10208066, Compound 40 | US10611777, Compound 40) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >333 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436094 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 339 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436076 (US10611777, Compound 23) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 343 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350446 (US10208066, Compound 68 | US10611777, Compound 68) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 345 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM436084 ((S)-4-amino-6-((1-(3-chloro-6-(o-tolyl)imidazo[1,2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 371 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350398 (US10208066, Compound 15 | US10611777, Compound 15) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 393 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350412 ((S)-4-amino-6-((1-(3-chloro-6-(3,5-difluorophenyl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436074 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 424 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350453 (US10208066, Compound 77 | US10611777, Compound 77) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 436 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350426 (US10208066, Compound 45 | US10611777, Compound 45) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350397 (US10208066, Compound 13 | US10611777, Compound 13) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 484 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350422 (US10208066, Compound 41 | US10611777, Compound 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 499 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM436074 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350450 (US10208066, Compound 72 | US10611777, Compound 72) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 513 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350396 (US10208066, Compound 12 | US10611777, Compound 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350443 (US10208066, Compound 65 | US10611777, Compound 65) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 611 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350401 (US10208066, Compound 18 | US10611777, Compound 18) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 617 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM436131 ((S)-N4-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazi...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350454 ((S)-4-amino-6-(0-(3-fluoro-6-phenylimidazo[1,2-b]p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 712 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436079 (US10611777, Compound 26) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG UniChem | US Patent | n/a | n/a | 839 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform (Homo sapiens (Human)) | BDBM436102 ((S)-6-amino-4-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | 957 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350446 (US10208066, Compound 68 | US10611777, Compound 68) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 963 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350399 (US10208066, Compound 16 | US10611777, Compound 16) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350402 (US10208066, Compound 19 | US10611777, Compound 19) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350403 ((s)-9-(1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350400 (US10208066, Compound 17 | US10611777, Compound 17) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350393 ((S)-4-amino-6-((1-(3-chloro-6-(pyridin-2-yl)imidaz...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350397 (US10208066, Compound 13 | US10611777, Compound 13) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350401 (US10208066, Compound 18 | US10611777, Compound 18) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350392 ((S)-4-amino-6-((1-(6-phenylimidazo[1,2-b]pyridazin...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350389 (4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]pyri...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350398 (US10208066, Compound 15 | US10611777, Compound 15) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PI3-kinase class I (Homo sapiens (Human)) | BDBM350391 ((S)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350412 ((S)-4-amino-6-((1-(3-chloro-6-(3,5-difluorophenyl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350402 (US10208066, Compound 19 | US10611777, Compound 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350444 (US10208066, Compound 66 | US10611777, Compound 66) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.12E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350445 (US10208066, Compound 67 | US10611777, Compound 67) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350437 (US10208066, Compound 59 | US10611777, Compound 59) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350440 (US10208066, Compound 62 | US10611777, Compound 62) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350443 (US10208066, Compound 65 | US10611777, Compound 65) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350417 (US10208066, Compound 36 | US10611777, Compound 36) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350427 (US10208066, Compound 46 | US10611777, Compound 46) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.32E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350429 (US10208066, Compound 48 | US10611777, Compound 48) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350422 (US10208066, Compound 41 | US10611777, Compound 41) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350397 (US10208066, Compound 13 | US10611777, Compound 13) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350402 (US10208066, Compound 19 | US10611777, Compound 19) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.97E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350448 (US10208066, Compound 70 | US10611777, Compound 70) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.98E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM350437 (US10208066, Compound 59 | US10611777, Compound 59) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| PIK3CG/PIK3R1 (Homo sapiens (Human)) | BDBM436078 (US10611777, Compound 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | KEGG UniChem | US Patent | n/a | n/a | 2.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350445 (US10208066, Compound 67 | US10611777, Compound 67) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350429 (US10208066, Compound 48 | US10611777, Compound 48) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.08E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350444 (US10208066, Compound 66 | US10611777, Compound 66) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Phosphatidylinositol 3-kinase regulatory subunit beta (Homo sapiens (Human)) | BDBM350390 ((R)-4-amino-6-((1-(3-chloro-6-phenylimidazo[1,2-b]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.81E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
HUTCHISON MEDIPHARMA LIMITED US Patent | Assay Description PI3K kinases including p110α/p85α and p110γ were purchased from Invitrogen, p110δ/p85α and p110β/p85α were from Mi... | US Patent US10611777 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
